Fuller & Thaler Asset Management Inc. lessened its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 71.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 2,130 shares of the company's stock after selling 5,260 shares during the quarter. Fuller & Thaler Asset Management Inc.'s holdings in Cardinal Health were worth $293,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in CAH. NewEdge Advisors LLC boosted its stake in Cardinal Health by 5.3% during the 4th quarter. NewEdge Advisors LLC now owns 12,429 shares of the company's stock worth $1,470,000 after purchasing an additional 622 shares during the last quarter. First Trust Advisors LP boosted its stake in Cardinal Health by 39.9% during the 4th quarter. First Trust Advisors LP now owns 222,764 shares of the company's stock worth $26,346,000 after purchasing an additional 63,535 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Cardinal Health by 1.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,238,848 shares of the company's stock worth $146,517,000 after purchasing an additional 15,212 shares during the last quarter. Tower Research Capital LLC TRC boosted its stake in Cardinal Health by 40.8% during the 4th quarter. Tower Research Capital LLC TRC now owns 13,342 shares of the company's stock worth $1,578,000 after purchasing an additional 3,869 shares during the last quarter. Finally, TD Waterhouse Canada Inc. boosted its stake in Cardinal Health by 253.0% during the 4th quarter. TD Waterhouse Canada Inc. now owns 2,358 shares of the company's stock worth $279,000 after purchasing an additional 1,690 shares during the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts have issued reports on CAH shares. Wells Fargo & Company reaffirmed an "overweight" rating and set a $185.00 target price (up previously from $183.00) on shares of Cardinal Health in a research note on Wednesday, August 13th. Robert W. Baird lifted their target price on shares of Cardinal Health from $197.00 to $203.00 and gave the stock an "outperform" rating in a research note on Wednesday, August 13th. Evercore ISI lowered their target price on shares of Cardinal Health from $200.00 to $190.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 13th. Leerink Partners reduced their price target on Cardinal Health from $188.00 to $186.00 and set an "outperform" rating on the stock in a report on Tuesday, August 12th. Finally, Jefferies Financial Group set a $150.00 price target on Cardinal Health in a report on Tuesday, August 12th. Twelve investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $163.20.
Get Our Latest Stock Report on CAH
Insider Transactions at Cardinal Health
In related news, CEO Jason M. Hollar sold 35,901 shares of the business's stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total value of $5,386,586.04. Following the sale, the chief executive officer directly owned 200,000 shares in the company, valued at approximately $30,008,000. The trade was a 15.22% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Jessica L. Mayer sold 38,078 shares of the business's stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the completion of the sale, the insider owned 48,457 shares in the company, valued at approximately $7,211,370.74. This trade represents a 44.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 271,676 shares of company stock worth $40,489,525 in the last 90 days. Insiders own 0.09% of the company's stock.
Cardinal Health Stock Performance
Shares of NYSE CAH traded down $3.5270 during trading on Friday, hitting $148.0430. 2,685,985 shares of the company were exchanged, compared to its average volume of 2,600,685. Cardinal Health, Inc. has a 12-month low of $106.54 and a 12-month high of $168.44. The company has a fifty day moving average price of $159.02 and a 200-day moving average price of $145.58. The firm has a market capitalization of $35.35 billion, a PE ratio of 22.95, a P/E/G ratio of 1.25 and a beta of 0.67.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. During the same quarter in the previous year, the firm earned $1.84 EPS. The company's quarterly revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.
Cardinal Health Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Investors of record on Wednesday, October 1st will be issued a $0.5107 dividend. This represents a $2.04 annualized dividend and a yield of 1.4%. The ex-dividend date is Wednesday, October 1st. Cardinal Health's payout ratio is 31.63%.
About Cardinal Health
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Recommended Stories

Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report